These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10371488)

  • 1. The NOD mouse model of type 1 diabetes: as good as it gets?
    Atkinson MA; Leiter EH
    Nat Med; 1999 Jun; 5(6):601-4. PubMed ID: 10371488
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 3. [An animal model of type 1 diabetes (NOD mice)].
    Nagata M
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():25-32. PubMed ID: 12355754
    [No Abstract]   [Full Text] [Related]  

  • 4. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
    Apostolou I; Von Boehmer H
    J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
    Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of insulin-dependent diabetes.
    Liu E; Yu L; Moriyama H; Eisenbarth GS
    Methods Mol Med; 2004; 102():195-212. PubMed ID: 15286387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
    Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
    Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.
    Haskins K
    J Autoimmun; 2004 Mar; 22(2):107-9. PubMed ID: 14987737
    [No Abstract]   [Full Text] [Related]  

  • 12. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
    Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.
    Mariño E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST
    Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin--a primary autoantigen in type 1 diabetes?
    Wong FS
    Trends Mol Med; 2005 Oct; 11(10):445-8. PubMed ID: 16150642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiopathogenic bases of insulin-dependent diabetes].
    Corbi C; Vimont S; Benoist JF; Legrand A; Lemonnier A
    Ann Biol Clin (Paris); 1994; 52(6):499-504. PubMed ID: 7856954
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.
    Boudaly S; Morin J; Berthier R; Marche P; Boitard C
    Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Pro)insulin-specific regulatory T cells.
    Harrison LC; Solly NR; Martinez NR
    Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune diabetes mellitus--much progress, but many challenges.
    McDevitt HO; Unanue ER
    Adv Immunol; 2008; 100():1-12. PubMed ID: 19111161
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 1 diabetes: focus on prevention.
    von Boehmer H
    Nat Med; 2004 Aug; 10(8):783-4. PubMed ID: 15286776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.